AVENTIS PHARMA S.A.
396Patents
76Active
396Granted
45Portfolio score
Filing activity: Dec 8, 1993 → Jul 11, 2017 · 63 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6139870A | Stabilized nanoparticles which are filterable under sterile conditions | Emerging Cross-Sectional Technologies | 145 | Expired |
| US6403569B1 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil | Human Necessities | 103 | Expired |
| US7491710B2 | Organophosphorus derivatives of indazoles and use thereof as medicinal products | Chemistry; Metallurgy | 90 | Active |
| US6794370B2 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil | Human Necessities | 85 | Expired |
| US7112592B2 | Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents | Human Necessities | 66 | Expired |
| US6333348A | Use of docetaxel for treating cancers | Human Necessities | 59 | Expired |
| US6939862B2 | Method for transferring nucleic acid into striated muscles | Human Necessities | 49 | Expired |
| US6355631B1 | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation | Chemistry; Metallurgy | 45 | Expired |
| US7041824B2 | Purine derivatives, preparation method and use as medicines | Chemistry; Metallurgy | 43 | Expired |
| USRE38743E1 | Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events | General | 42 | Expired |
| US6300321A | Compounds, preparation and use for transferring nucleic acids into cells | Chemistry; Metallurgy | 42 | Expired |
| US6214863A | Antitumor compositions containing taxane derivatives | Chemistry; Metallurgy | 41 | Expired |
| US6632427B1 | Adenoviral-vector-mediated gene transfer into medullary motor neurons | Chemistry; Metallurgy | 39 | Expired |
| US7470781B2 | Formulation of stabilized cationic transfection agent(s)/nucleic acid particles | Human Necessities | 36 | Expired |
| US6858638B2 | Substituted indazoles, compositions containing them, method of production and use | Human Necessities | 35 | Expired |
| US6569993B1 | Process for the preparation of resin-bound cyclic peptides | Chemistry; Metallurgy | 33 | Expired |
| US6479479B2 | Azetidine derivatives, their preparation and pharmaceutical compositions containing them | Chemistry; Metallurgy | 33 | Expired |
| US6960596B2 | Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer | Human Necessities | 33 | Expired |
| US6403610B1 | Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them | Chemistry; Metallurgy | 32 | Expired |
| US7674795B2 | Fluorene derivatives, composition containing said derivatives and the use thereof | Chemistry; Metallurgy | 32 | Active |
| US6133024A | Gene expression control | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6756523B1 | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain | Chemistry; Metallurgy | 31 | Expired |
| US7067133B2 | Methods and compositions for diseases associated with amyloidosis | Chemistry; Metallurgy | 30 | Expired |
| US7033826B2 | Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses | Chemistry; Metallurgy | 29 | Expired |
| US6346543B1 | Use of a taxoid to treat abnormal cell proliferation in the brain | Human Necessities | 28 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.